Department of Laboratory Medicine and Genetics, Sungkyunkwan University School of Medicine, Seoul, Korea.
Division of Hematology and Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Lab Med. 2020 Sep;40(5):409-413. doi: 10.3343/alm.2020.40.5.409.
Epidemiological studies of monoclonal B-cell lymphocytosis (MBL) have been conducted in limited geographical regions. Little is known about the prevalence of MBL in Asia. We investigated the prevalence and immunophenotypic characteristics of MBL in Koreans who had idiopathic lymphocytosis (lymphocyte count >4.0×109/L) and were ≥40 years of age. A total of 105 leftover peripheral blood samples met these criteria among those from 73,727 healthy individuals who visited the Health Promotion Center, Samsung Medical Center, Korea, from June 2018 to August 2019. The samples were analyzed using eight-color flow cytometry with the following monoclonal antibodies: CD45, CD5, CD10, CD19, CD20, CD23, and kappa and lambda light chains. The overall prevalence of MBL in the study population was 2.9% (3/105); there was one case of chronic lymphocytic leukemia (CLL)-like MBL (CD5+CD23+), one case of atypical CLL-like MBL (CD5+CD23-), and one case of CD5-MBL with a lambda restriction pattern. This is the first study on the MBL prevalence in an East Asian population, and it reveals a relatively low prevalence of MBL in healthy Korean individuals with lymphocytosis.
对单克隆 B 细胞淋巴增生症 (MBL) 的流行病学研究仅在有限的地理区域进行过。亚洲地区 MBL 的患病率知之甚少。我们调查了韩国人特发性淋巴增生(淋巴细胞计数>4.0×109/L)且年龄≥40 岁的人群中 MBL 的患病率和免疫表型特征。2018 年 6 月至 2019 年 8 月,韩国三星医疗中心健康促进中心对 73727 名健康个体进行了外周血样本检测,从中共挑选出 105 份符合上述标准的剩余外周血样本。这些样本使用带有以下单克隆抗体的 8 色流式细胞术进行分析:CD45、CD5、CD10、CD19、CD20、CD23、kappa 和 lambda 轻链。研究人群中 MBL 的总体患病率为 2.9%(3/105);有一例慢性淋巴细胞白血病(CLL)样 MBL(CD5+CD23+),一例非典型 CLL 样 MBL(CD5+CD23-)和一例 CD5-MBL 伴 lambda 限制模式。这是东亚人群中关于 MBL 患病率的第一项研究,结果表明在韩国有淋巴增生的健康个体中,MBL 的患病率相对较低。